Pavani Malla, MS

Research Associate

Research Interests:
Tyrosine Kinase Signaling

Selected Publications:

  • Mahajan K, Malla P, Lawrence HR, Chen Z, Sinha CK, Malik R, Shukla S, Kim J, Coppola D, Lawrence NJ and Mahajan NP*. ACK1/TNK2 Regulates Histone H4 Tyr88-phosphorylation and AR Gene Expression in Castration-Resistant Prostate Cancer. Cancer Cell 2017. Pubmed ID:  28609657

 

  • Mahajan K, Malla P, Sarnaik A, Kim J, Pilon-Thomas S, Weber J and Mahajan NP*. WEE1 epigenetically modulates 5-hmC levels. Oncotarget 2017. Pubmed ID:

  • Wu X, Zahari MS, Renuse S, Bharbuiya MA, Rojas PL, Kelkar DS, Sterns V, Gabrielson E, Sukumar S, Malla P, Mahajan NP*, Pandey A*. The non-receptor Tyrosine kinase ATNK2/ACK1 is a novel therapeutic target in triple negative breast cancer. Oncotarget 2016. Pubmed ID: 27902967

 

 

Pavani Malla

BSc, Andhra University

MS., Texas A&M University 

Contact:
SRB-4, Lab # 24234
Moffitt Cancer Center
12902 Magnolia Drive
Tampa, Florida 33612

Email:

pavani.malla@moffitt.org

Phone:
Lab: 813-745-6713